Psychedelics show promise for depression and anxiety. Federal support is growing, but drugs are advancing at different speeds ...
In a nationally representative study on psilocybin use and mental health treatment, researchers at the University of ...
People with alcohol use disorder who were still abstinent three months after psilocybin-assisted therapy tended to describe their first psychedelic session differently than those who had returned to ...
In a nationally representative study on psilocybin use and mental health treatment, researchers at the University of ...
People living with persistent suicidal thoughts may find relief from psilocybin paired with structured psychological support, ...
Obsessive–compulsive disorder (OCD) is a psychiatric condition characterized by recurrent obsessions, or unwanted thoughts, ...
A team of USC researchers has received an up to $4 million award from the Advanced Research Projects Agency for Health ...
A pilot RCT links psilocybin's 25 mg dose to reduced egocentric bias in alcohol use disorder, exposing a blind spot in how ...
Unlike acute pain, which shuts down the brain’s "self network" (Default Mode Network), movement-triggered flares in chronic ...
Depression affects nearly 40% of individuals diagnosed with lung cancer, frequently accompanied by anxiety, hopelessness, and ...
A nationally representative UC San Diego study finds that people with depression who use psilocybin continue to seek conventional mental health care at rates similar to nonusers, while reporting ...
The UK-based Compass Pathways, a synthetic psilocybin company, opened their U.S. office in Jersey City, cutting the ribbon ...